All Comments by Greg Hook
- Does δ-Secretase Prep APP for BACE1, Boost Aβ production?
- In APP Knock-Ins, Calcium Chaos Dismantles Mushroom Spines
- Translational study of Alzheimer's disease (AD) biomarkers from brain tissues in AβPP/PS1 mice and serum of AD patients.
- Exosomes Divulge Lysosomal Unrest, Signal AD?
- The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
- SfN: The Old and the New—BACE and Cathepsin B Share the β-secretase Stage
- Leon Thal Symposium Webinar
- Leon Thal Symposium Webinar
- Leon Thal Symposium Webinar
- Leon Thal Symposium Webinar
- Keystone Drug News: Pyroglu Aβ—Snowball That Touches Off Avalanche?
- SfN: The Old and the New—BACE and Cathepsin B Share the β-secretase Stage
- SfN: The Old and the New—BACE and Cathepsin B Share the β-secretase Stage
- Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.